inaustin 1 / 10 Oct 16, 2011 #1One of our star medicines ---Artemether Injection (Anti-malaria) was detected 2% below standard and thus resulted in a "Non-conformation" test report. The standard content should be above 97%, but our goods were tested to have only 95%, which means the anti-malaria effect may not be strong enough to African people. After investigations, we found that batch of goods was actually out of original production schedule; it was added to production line at short notice for one customer's need.Urgent demand caused a slapdash producing adjustment which made content percent setting retained at Asia lever for previous goods to Cambodia.Considering about saving time and our long-time warranted quality, we expedited shipment without waiting for the test paper. So the goods were already on the way to Nigeria when we received the non-conformation report.Pls, correct or refine any place where u read uncomfortable.If any details confuse u , pls highlight.THX
